Atherectomy Devices Market Size, Share and Growth Outlook, 2026

Atherectomy Devices Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Atherectomy Devices Market size is forecast to increase from $1.19 Billion in 2026 to $2.25 Billion in 2034 at a CAGR of 8.3% between 2026 and 2034.

The Atherectomy Devices market report provides detailed analysis and outlook of Atherectomy Devices segments including By Product Type (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices), By Component (Instruments / Consoles, Consumables & Accessories ), By Application (Peripheral Vascular Applications / Peripheral Artery Disease, Cardiovascular Applications / Coronary Artery Disease, Neurovascular Applications), By End-User (Hospitals and Inpatient Cardiac Centers, Ambulatory Surgical Centers, Specialized Vascular Clinics & Catheterization Laboratories) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Atherectomy Devices Industry Overview

Advancements in Atherectomy Technologies for Calcified and Peripheral Artery Disease Lesions

The atherectomy devices industry is evolving rapidly as healthcare providers increasingly adopt minimally invasive plaque modification technologies for the treatment of peripheral artery disease (PAD) and complex coronary artery disease. Growing prevalence of vascular calcification, aging populations, and rising demand for endovascular interventions are driving innovation in directional, rotational, and orbital atherectomy systems. Manufacturers are focusing on improving procedural precision, vessel safety, and treatment effectiveness through the integration of advanced imaging capabilities and enhanced plaque removal mechanisms. The industry continues to benefit from technological advancements that enable physicians to address challenging lesions while reducing procedural complexity and improving patient outcomes.

Imaging-Guided Atherectomy Driving Procedural Precision

A key trend shaping the atherectomy devices market is the integration of real-time imaging technologies into plaque excision systems. Avinger announced the full commercial rollout of the Pantheris LV directional atherectomy system, specifically designed for the treatment of peripheral artery disease in large vessels such as the superficial femoral artery. The platform incorporates upgraded plaque excision speeds and real-time optical coherence tomography (OCT) imaging directly within the catheter tip, enabling physicians to visualize vessel structures during treatment and optimize procedural safety. The adoption of image-guided atherectomy systems is enhancing lesion targeting accuracy and supporting more precise endovascular interventions.

Regulatory and Reimbursement Updates Supporting Market Adoption

Healthcare policy developments are contributing to broader adoption of atherectomy procedures across clinical settings. The Centers for Medicare & Medicaid Services finalized updated Diagnostic Related Group classifications and coding structures covering percutaneous coronary intervention procedures involving orbital, rotational, and directional atherectomy techniques. The revised framework establishes standardized inpatient and outpatient reimbursement criteria and uniform billing structures across healthcare institutions. These reimbursement updates improve procedural clarity for providers and support wider integration of atherectomy technologies into cardiovascular treatment pathways.

Clinical Evidence and Product Innovation Expanding Treatment Applications

Manufacturers continue to enhance device performance while generating clinical evidence to support broader use of atherectomy and related plaque modification therapies. Boston Scientific expanded the deployment of its ROTAPRO Rotational Atherectomy System, featuring streamlined product architecture and a diamond-tipped burr engineered to treat heavily calcified coronary lesions during complex percutaneous coronary interventions. The system emphasizes simplified laboratory setup and efficient transport for outpatient environments. Clinical momentum is also being driven by data from the RollerCoastr-EPIC22 randomized controlled trial, which evaluated rotational atherectomy, excimer laser coronary angioplasty, and intravascular lithotripsy for calcified coronary stenosis treatment. Additionally, findings from the EMPOWER CAD study highlighted the use of intravascular lithotripsy for calcified lesions in female patients, addressing longstanding gaps in real-world cardiovascular treatment data and reinforcing the growing importance of plaque modification technologies in complex coronary interventions.

Atherectomy Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Atherectomy Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Abbott Laboratories (Cardiovascular Systems, Inc.), Boston Scientific Corporation, Medtronic plc, Koninklijke Philips N.V., Becton, Dickinson and Company (BD), Avinger, Inc., Cardiovascular Systems, Inc. (CSI), Shockwave Medical (Johnson & Johnson MedTech), Biotronik SE & Co. KG, Cardinal Health (Cordis). The Atherectomy Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Atherectomy Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Atherectomy Devices Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Atherectomy Devices companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Atherectomy Devices markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Atherectomy Devices Market Competitive Benchmarking and Company Analysis

Leading companies in Atherectomy Devices industry include- Abbott Laboratories (Cardiovascular Systems, Inc.), Boston Scientific Corporation, Medtronic plc, Koninklijke Philips N.V., Becton, Dickinson and Company (BD), Avinger, Inc., Cardiovascular Systems, Inc. (CSI), Shockwave Medical (Johnson & Johnson MedTech), Biotronik SE & Co. KG, Cardinal Health (Cordis). The Atherectomy Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Atherectomy Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Atherectomy Devices market remains one of the strongest-performing segments in the country.
The US Atherectomy Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Atherectomy Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Atherectomy Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Atherectomy Devices markets

Canada's strong Atherectomy Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Atherectomy Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Atherectomy Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Atherectomy Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Atherectomy Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Atherectomy Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Atherectomy Devices market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Atherectomy Devices sales through 2034

France Atherectomy Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Atherectomy Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Atherectomy Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Atherectomy Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Atherectomy Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Atherectomy Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Atherectomy Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Atherectomy Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Atherectomy Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Atherectomy Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Atherectomy Devices Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Atherectomy Devices Market Segmentation

By Product Type
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Component
Instruments / Consoles
Consumables & Accessories
By Application
Peripheral Vascular Applications / Peripheral Artery Disease
Cardiovascular Applications / Coronary Artery Disease
Neurovascular Applications
By End-User
Hospitals and Inpatient Cardiac Centers
Ambulatory Surgical Centers
Specialized Vascular Clinics & Catheterization Laboratories

Top Companies in Atherectomy Devices Industry

Abbott Laboratories (Cardiovascular Systems, Inc.)
Boston Scientific Corporation
Medtronic plc
Koninklijke Philips N.V.
Becton, Dickinson and Company (BD)
Avinger, Inc.
Cardiovascular Systems, Inc. (CSI)
Shockwave Medical (Johnson & Johnson MedTech)
Biotronik SE & Co. KG
Cardinal Health (Cordis)

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025